Scientists Develop Parkinson’s Drug from Plastic Bottles Using Engineered Bacteria

ISLAMABAD: In a groundbreaking study, researchers have created a drug to treat Parkinson’s disease using plastic bottles as a raw material through a natural biological process.

For the first time, plastic waste has been transformed into a life-improving medication for neurological patients. Scientists at the University of Edinburgh engineered E. coli bacteria to break down polyethylene terephthalate (PET)—the plastic commonly used in food and beverage packaging—into L-DOPA, a key compound used in Parkinson’s treatment.

Traditionally, Parkinson’s drugs rely on fossil fuel-based production methods, making this approach more sustainable by repurposing plastic waste. This innovation not only addresses environmental concerns but also provides a potential new source for essential neurological medications.